Fulcrum Therapeutics Inc
NASDAQ:FULC
Wall Street
Price Targets
FULC Price Targets Summary
Fulcrum Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
FULC
is 13.52 USD
with a low forecast of 5.05 USD and a high forecast of 19.95 USD.
FULC Last Price Targets
Fulcrum Therapeutics Inc
The latest public price target was made on Mar 13, 2024 by
Gregory Renza
from
RBC Capital
,
who expects
FULC
stock to
rise by 91%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Gregory Renza
RBC Capital
|
14
USD
Upside 91% |
1 month ago
Mar 13, 2024
|
RBC Capital Starts Fulcrum Therapeutics (FULC) at Outperform, 'A Rare Disease Pipeline with Its DUX in a Row'
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is FULC's stock price target?
Price Target
13.52
USD
According to Wall Street analysts, the average 1-year price target for
FULC
is 13.52 USD
with a low forecast of 5.05 USD and a high forecast of 19.95 USD.
What is Fulcrum Therapeutics Inc's Revenue forecast?
Projected CAGR
187%
The
compound annual growth rate
of Fulcrum Therapeutics Inc's revenue for the next 3 years is
187%.
You don't have any saved screeners yet
